Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

NCT00002032 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycobacterium Avium-intracellulare Infection
HIV Infections

Interventions

DRUG: Rifabutin

Sponsor

Pharmacia